In today’s fast-paced world, respiratory health has become a significant concern for many individuals. Conditions such as ...

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...

This study aimed to examine changes in self-reported respiratory symptoms over 5 years, as well as to examine the lung function decline and determine whether it is within the expected range, to assess ...

In today’s fast-paced world, respiratory health has become a pressing concern for many. With increasing pollution, sedentary lifestyles, and a rise in respiratory diseases, finding effective ...

1 Factors affecting pulmonary function in patients with DMD were evaluated in new research, which leveraged data from patients at the Hospital for Sick Children (SickKids), Rady Children’s ...

The average life expectancy is 3 years from the onset of symptoms, and patients usually die due to respiratory failure. Respiratory function is an important predictor of survival and quality of life ...

None of these patients, however, had clinical evidence of deterioration of their disease. Patients with sarcoidosis had no appreciable alteration in pulmonary function tests. The influence of various ...

Correspondence to Dr Rebecca F D'Cruz; rebecca.dcruz{at}nhs.net ...

Vatican reports Pope Francis showing improvement after week-long hospitalization for pneumonia and respiratory infection.

The partnership will enhance the clinic’s ability to provide specialized respiratory care and reinforce its commitment to ...

Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase ...